(Q37141191)

18 August 2017

1 reference

title

When primary antifungal therapy fails (English)

1 reference

18 August 2017

Marcio Nucci

1

0 references

John R Perfect

series ordinal

2

object named as

John R Perfect

1 reference

PubMed ID

18419447

18 August 2017

language of work or name

English

0 references

publication date

1 May 2008

1 reference

Clinical Infectious Diseases

18 August 2017

1 reference

18 August 2017

46

1 reference

18 August 2017

1426-1433

1 reference

18 August 2017

9

1 reference

Advances and challenges in management of invasive mycoses

18 August 2017

1 reference

Clinical efficacy of new antifungal agents

21 January 2018

1 reference

Cryptococcosis in human immunodeficiency virus-negative patients in the era of effective azole therapy

21 January 2018

1 reference

Voriconazole versus a regimen of amphotericin B followed by fluconazole for candidaemia in non-neutropenic patients: a randomised non-inferiority trial

21 January 2018

1 reference

Micafungin versus liposomal amphotericin B for candidaemia and invasive candidosis: a phase III randomised double-blind trial

21 January 2018

1 reference

Comparison of caspofungin and amphotericin B for invasive candidiasis

21 January 2018

1 reference

Micafungin versus caspofungin for treatment of candidemia and other forms of invasive candidiasis

21 January 2018

1 reference

Anidulafungin versus fluconazole for invasive candidiasis

21 January 2018

1 reference

A randomized and blinded multicenter trial of high-dose fluconazole plus placebo versus fluconazole plus amphotericin B as therapy for candidemia and its consequences in nonneutropenic subjects.

21 January 2018

1 reference

Liposomal amphotericin B as initial therapy for invasive mold infection: a randomized trial comparing a high-loading dose regimen with standard dosing (AmBiLoad trial)

21 January 2018

1 reference

Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis

21 January 2018

1 reference

A double-blind, randomized, controlled trial of amphotericin B colloidal dispersion versus amphotericin B for treatment of invasive aspergillosis in immunocompromised patients

21 January 2018

1 reference

An EORTC international multicenter randomized trial (EORTC number 19923) comparing two dosages of liposomal amphotericin B for treatment of invasive aspergillosis.

21 January 2018

1 reference

Outcome predictors of 84 patients with hematologic malignancies and Fusarium infection.

21 January 2018

1 reference

Immune reconstitution syndrome associated with opportunistic mycoses

21 January 2018

1 reference

Risk factors for death among cancer patients with fungemia.

21 January 2018

1 reference

Candidemia at a tertiary-care hospital: epidemiology, treatment, clinical outcome and risk factors for death

21 January 2018

1 reference

Characteristics of candidaemia with Candida-albicans compared with non-albicans Candida species and predictors of mortality

21 January 2018

1 reference

Prognostic factors for death due to invasive aspergillosis after hematopoietic stem cell transplantation: a 1-year retrospective study of consecutive patients at French transplantation centers

21 January 2018

1 reference

Discontinuation of maintenance therapy for cryptococcal meningitis in patients with AIDS treated with highly active antiretroviral therapy: an international observational study

21 January 2018

1 reference

Immune reconstitution inflammatory syndrome producing atypical presentations of cryptococcal meningitis: case report and a review of immune reconstitution-associated cryptococcal infections.

21 January 2018

1 reference

An immune reconstitution syndrome-like illness associated with Cryptococcus neoformans infection in organ transplant recipients

21 January 2018

1 reference

Development of interpretive breakpoints for antifungal susceptibility testing: conceptual framework and analysis of in vitro-in vivo correlation data for fluconazole, itraconazole, and candida infections. Subcommittee on Antifungal Susceptibility Te

21 January 2018

1 reference

Comparative in-vitro activity of voriconazole (UK-109,496) and six other antifungal agents against clinical isolates of Scedosporium prolificans and Scedosporium apiospermum.

21 January 2018

1 reference

Aspergillus terreus: an emerging amphotericin B-resistant opportunistic mold in patients with hematologic malignancies

21 January 2018

1 reference

Voriconazole : a review of its use in the management of invasive fungal infections

21 January 2018

1 reference

Scedosporium infection in a tertiary care cancer center: a review of 25 cases from 1989-2006.

21 January 2018

1 reference

Molecular studies reveal frequent misidentification of Aspergillus fumigatus by morphotyping

21 January 2018

1 reference

Antifungal susceptibility survey of 2,000 bloodstream Candida isolates in the United States.

21 January 2018

1 reference

Caspofungin susceptibility testing of isolates from patients with esophageal candidiasis or invasive candidiasis: relationship of MIC to treatment outcome

21 January 2018

1 reference

Results obtained with various antifungal susceptibility testing methods do not predict early clinical outcome in patients with cryptococcosis

21 January 2018

1 reference

Aspergillus susceptibility testing in patients with cancer and invasive aspergillosis: difficulties in establishing correlation between in vitro susceptibility data and the outcome of initial amphotericin B therapy

21 January 2018

1 reference

Candida glabrata fungemia in transplant patients receiving voriconazole after fluconazole

21 January 2018

1 reference

Clinical significance of azole antifungal drug cross-resistance in Candida glabrata

21 January 2018

1 reference

Acquired resistance to echinocandins in Candida albicans: case report and review

21 January 2018

1 reference

Emergence of a Candida krusei isolate with reduced susceptibility to caspofungin during therapy

21 January 2018

1 reference

Multiechinocandin- and multiazole-resistant Candida parapsilosis isolates serially obtained during therapy for prosthetic valve endocarditis

21 January 2018

1 reference

Multi-azole resistance in Aspergillus fumigatus

21 January 2018

1 reference

Susceptibility testing of sequential isolates of Aspergillus fumigatus recovered from treated patients.

21 January 2018

1 reference

Symptomatic relapse of HIV-associated cryptococcal meningitis after initial fluconazole monotherapy: the role of fluconazole resistance and immune reconstitution.

21 January 2018

1 reference

Antifungal susceptibility of Candida biofilms: unique efficacy of amphotericin B lipid formulations and echinocandins

21 January 2018

1 reference

Candida infections of medical devices

21 January 2018

1 reference

Potent cytochrome P450 2C19 genotype–related interaction between voriconazole and the cytochrome P450 3A4 inhibitor ritonavir

21 January 2018

1 reference

Drug-drug interactions of antifungal agents and implications for patient care

21 January 2018

1 reference

Mycoses in pediatric patients

21 January 2018

1 reference

Pharmacokinetics of micafungin in healthy volunteers, volunteers with moderate liver disease, and volunteers with renal dysfunction

21 January 2018

1 reference

Assessment of the paradoxical effect of caspofungin in therapy of candidiasis

21 January 2018

1 reference

Systemic antifungal agents. Drug interactions of clinical significance

21 January 2018

1 reference

Effect of rifampicin on the pharmacokinetics of fluconazole in patients with AIDS.

21 January 2018

1 reference

Voriconazole: a new triazole antifungal agent

21 January 2018

1 reference

Pharmacological properties and clinical efficacy of a recently licensed systemic antifungal, caspofungin

21 January 2018

1 reference

Mortality and costs of acute renal failure associated with amphotericin B therapy

21 January 2018

1 reference

Predictors of pulmonary zygomycosis versus invasive pulmonary aspergillosis in patients with cancer

21 January 2018

1 reference

Comparison of histopathological analysis, culture, and polymerase chain reaction assays to detect invasive mold infections from biopsy specimens

21 January 2018

1 reference

Aspergillosis: The most common community-acquired pneumonia with gram-negative Bacilli as copathogens in stem cell transplant recipients with graft-versus-host disease.

21 January 2018

1 reference

Coexistent cutaneous Aspergillus and cytomegalovirus infection in a liver transplant recipient

21 January 2018

1 reference

Fatal case of Aspergillus coinfection in a renal transplant recipient suffering from cytomegalovirus pneumonitis.

21 January 2018

1 reference

Combination antifungal therapy for invasive aspergillosis

21 January 2018

1 reference

Aspergillus ustus infections among transplant recipients

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1086/587101

1 reference

18 August 2017

1 reference

PubMed ID

18419447